CMS posts final decision memo for PET

03/8/2013

On Thursday, March 7, the Centers for Medicare & Medicaid Services posted its final decision memo for PET. This reconsideration followed a letter from the Medical Imaging Technology Alliance requesting that CMS remove the current non-coverage language for new PET radiopharmaceuticals that receive approval from the Food and Drug Administration. CMS will allow local coverage options for oncologic indications of FDA-approved PET tracers after Sept. 1, 2013.

View Full Article in:

http://www.snmmi.org/index.cfm?PageID=12449%20

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY